Bleeding risk with ischemic stroke therapy - Reply
Type
Journal articleSubject
Science & TechnologyLife Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
TISSUE-PLASMINOGEN ACTIVATOR
INTRACEREBRAL HEMORRHAGE
THROMBOLYSIS
Permalink
https://hdl.handle.net/10161/21643Published Version (Please cite this version)
10.1001/2012.jama.11667Publication Info
(2012). Bleeding risk with ischemic stroke therapy - Reply. JAMA - Journal of the American Medical Association, 308(13). pp. 1319-1320. 10.1001/2012.jama.11667. Retrieved from https://hdl.handle.net/10161/21643.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Eric David Peterson
Fred Cobb, M.D. Distinguished Professor of Medicine
Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of
Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical
Research Institute (DCRI), Durham, NC, USA.
Dr Peterson is the Principal Investigator of the National Institute of Health, Lung
and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional
Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial He is also
the Principal I
This author no longer has a Scholars@Duke profile, so the information shown here reflects
their Duke status at the time this item was deposited.
Ying Xian
Adjunct Associate Professor in the Department of Neurology
Alphabetical list of authors with Scholars@Duke profiles.
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info